Cargando…

The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway

BACKGROUND: Reduning (RDN) is a common Chinese medicine preparation with antibacterial, anti-inflammatory, antiviral and immunomodulatory effects in respiratory infectious diseases. Clinically, it is used in combination with antibiotics, but its synergistic effect and mechanism in treating severe pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Shanjun, Gan, Lianfang, Liu, Shengxing, Zhong, Lifan, Chen, Meiling, Zhang, Hong, Li, Jiankang, Huang, Ling, Lv, Chuanzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902113/
https://www.ncbi.nlm.nih.gov/pubmed/35280469
http://dx.doi.org/10.21037/jtd-22-126
_version_ 1784664524178063360
author Luo, Shanjun
Gan, Lianfang
Liu, Shengxing
Zhong, Lifan
Chen, Meiling
Zhang, Hong
Li, Jiankang
Huang, Ling
Lv, Chuanzhu
author_facet Luo, Shanjun
Gan, Lianfang
Liu, Shengxing
Zhong, Lifan
Chen, Meiling
Zhang, Hong
Li, Jiankang
Huang, Ling
Lv, Chuanzhu
author_sort Luo, Shanjun
collection PubMed
description BACKGROUND: Reduning (RDN) is a common Chinese medicine preparation with antibacterial, anti-inflammatory, antiviral and immunomodulatory effects in respiratory infectious diseases. Clinically, it is used in combination with antibiotics, but its synergistic effect and mechanism in treating severe pneumonia remain unclear. METHODS: A rat model of severe pneumonia and an in vitro coculture model consisting of A549 and THP-1 cells were used to observe the synergistic effect of RDN on severe pneumonia. The inflammatory cytokines were tested by enzyme-linked immunosorbent assay (ELISA). The localization of Aryl hydrocarbon receptor (AhR) in A549 cells was observed by immunofluorescence, and the interaction of AhR and signal transducer and activator of transcription 3 (STAT3) proteins was observed by co-immunoprecipitation. AhR-Src tyrosine kinase (Src)-STAT3 pathway in rats and A549 cells were examined by Western Blot. Histopathological changes were observed by Hematoxylin-eosin (HE) staining, X-ray and survival rates were used to evaluate the effects of paclitaxel on severe pneumonia rats. RESULTS: RDN regulation of Src–STAT3–interleukin 10 (IL-10) signaling pathway activation and macrophage polarization were mediated through the nuclear receptor AhR. The expression of AhR was significantly increased after RDN treatment, and this effect was accompanied by STAT3 expression increasing. Coimmunoprecipitation confirmed an interaction between AhR and STAT3 and upregulated IL-10 expression. Silencing AhR decreased Src, STAT3, and IL-10 expression. RDN activated AhR and increased Src, STAT3, and IL-10 expression. In addition, RDN regulated the polarization of macrophages RDN combined with cefmetazole sodium significantly reduced the pulmonary bacterial load, alleviated lung injury, and reduced o inflammatory factors expression, improving their survival. CONCLUSIONS: RDN can synergistically enhance the effect of cefmetazole sodium treatment in severe pneumonia, and the mechanism may involve increasing the expression level of IL-10 mediated through the AhR-Src-STAT3 pathway, driving the polarization of macrophages, and attenuating the cytokine storm to control inflammation in severe pneumonia.
format Online
Article
Text
id pubmed-8902113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-89021132022-03-10 The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway Luo, Shanjun Gan, Lianfang Liu, Shengxing Zhong, Lifan Chen, Meiling Zhang, Hong Li, Jiankang Huang, Ling Lv, Chuanzhu J Thorac Dis Original Article BACKGROUND: Reduning (RDN) is a common Chinese medicine preparation with antibacterial, anti-inflammatory, antiviral and immunomodulatory effects in respiratory infectious diseases. Clinically, it is used in combination with antibiotics, but its synergistic effect and mechanism in treating severe pneumonia remain unclear. METHODS: A rat model of severe pneumonia and an in vitro coculture model consisting of A549 and THP-1 cells were used to observe the synergistic effect of RDN on severe pneumonia. The inflammatory cytokines were tested by enzyme-linked immunosorbent assay (ELISA). The localization of Aryl hydrocarbon receptor (AhR) in A549 cells was observed by immunofluorescence, and the interaction of AhR and signal transducer and activator of transcription 3 (STAT3) proteins was observed by co-immunoprecipitation. AhR-Src tyrosine kinase (Src)-STAT3 pathway in rats and A549 cells were examined by Western Blot. Histopathological changes were observed by Hematoxylin-eosin (HE) staining, X-ray and survival rates were used to evaluate the effects of paclitaxel on severe pneumonia rats. RESULTS: RDN regulation of Src–STAT3–interleukin 10 (IL-10) signaling pathway activation and macrophage polarization were mediated through the nuclear receptor AhR. The expression of AhR was significantly increased after RDN treatment, and this effect was accompanied by STAT3 expression increasing. Coimmunoprecipitation confirmed an interaction between AhR and STAT3 and upregulated IL-10 expression. Silencing AhR decreased Src, STAT3, and IL-10 expression. RDN activated AhR and increased Src, STAT3, and IL-10 expression. In addition, RDN regulated the polarization of macrophages RDN combined with cefmetazole sodium significantly reduced the pulmonary bacterial load, alleviated lung injury, and reduced o inflammatory factors expression, improving their survival. CONCLUSIONS: RDN can synergistically enhance the effect of cefmetazole sodium treatment in severe pneumonia, and the mechanism may involve increasing the expression level of IL-10 mediated through the AhR-Src-STAT3 pathway, driving the polarization of macrophages, and attenuating the cytokine storm to control inflammation in severe pneumonia. AME Publishing Company 2022-02 /pmc/articles/PMC8902113/ /pubmed/35280469 http://dx.doi.org/10.21037/jtd-22-126 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Luo, Shanjun
Gan, Lianfang
Liu, Shengxing
Zhong, Lifan
Chen, Meiling
Zhang, Hong
Li, Jiankang
Huang, Ling
Lv, Chuanzhu
The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title_full The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title_fullStr The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title_full_unstemmed The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title_short The synergistic Reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the AhR-Src-STAT3 pathway
title_sort synergistic reduning and cefmetazole sodium treatment of severe pneumonia is mediated by the ahr-src-stat3 pathway
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902113/
https://www.ncbi.nlm.nih.gov/pubmed/35280469
http://dx.doi.org/10.21037/jtd-22-126
work_keys_str_mv AT luoshanjun thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT ganlianfang thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT liushengxing thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT zhonglifan thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT chenmeiling thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT zhanghong thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT lijiankang thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT huangling thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT lvchuanzhu thesynergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT luoshanjun synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT ganlianfang synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT liushengxing synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT zhonglifan synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT chenmeiling synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT zhanghong synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT lijiankang synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT huangling synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway
AT lvchuanzhu synergisticreduningandcefmetazolesodiumtreatmentofseverepneumoniaismediatedbytheahrsrcstat3pathway